Hap Trading, LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

$1.15 Trillion
Q4 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $77,518 - $88,170	100 Added 2.94%	3,500 $217 Million
Q3 2023 Nov 09, 2023	BUY	$692.45 - $844.37 $2.35 Million - $2.87 Million	3,400 New	3,400 $2.8 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $57,397 - $72,432	-100 Reduced 1.61%	6,100 $506,000
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $1.32 Million - $1.77 Million	2,400 Added 63.16%	6,200 $229,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $3.63 Million - $4.26 Million	-6,100 Reduced 61.62%	3,800 $385,000
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $326,088 - $402,582	-600 Reduced 5.71%	9,900 $643,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $1.72 Million - $2.04 Million	3,000 Added 40.0%	10,500 $604,000
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $1.99 Million - $2.35 Million	-4,200 Reduced 35.9%	7,500 $462,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $1.88 Million - $2.3 Million	-4,200 Reduced 26.42%	11,700 $280,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $1.15 Million - $1.46 Million	2,400 Added 17.78%	15,900 $314,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $2.61 Million - $3.16 Million	4,800 Added 55.17%	13,500 $699,000
Q2 2020 Aug 10, 2020	BUY	$493.32 - $643.92 $1.97 Million - $2.58 Million	4,000 Added 85.11%	8,700 $1.1 Million
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $1.58 Million - $2.32 Million	4,700 New	4,700 $329,000
Q1 2018 May 11, 2018	SELL	$315.82 - $393.78 $3.28 Million - $4.1 Million	-10,400 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $71,726 - $93,990	200 Added 1.96%	10,400 $29,000
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $4.4 Million - $5.14 Million	10,200	10,200 $595,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

9.29M
Shares

$6.62 Billion
0.12% of portfolio
Black Rock Inc. New York, NY

8.45M
Shares

$6.02 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

7.06M
Shares

$5.04 Billion
0.41% of portfolio
State Street Corp Boston, MA

4.83M
Shares

$3.45 Billion
0.14% of portfolio
Capital International Investors Los Angeles, CA

4.74M
Shares

$3.38 Billion
0.66% of portfolio

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.

Account